Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Barco NV | BAR | Sep 19, 2024 | 12.14 | +1.51 |
Basilix | BAS | Sep 19, 2024 | 25.00 | 0.00 |
Beaulieu Av Certificates | BEAB | Sep 19, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Sep 19, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Sep 19, 2024 | 4 253.10 | +0.67 |
Belreca - Belgian Resources and Capital Company | BELR | Sep 19, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Sep 19, 2024 | 1.60 | 0.00 |
Belysse Group N.V. | BELYS | Sep 19, 2024 | 0.88 | -0.57 |
Biocartis Group NV | BCART | Sep 19, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Sep 19, 2024 | 0.01 | +1.25 |
Biotalys | BTLS | Sep 19, 2024 | 3.10 | 0.00 |
Boeing | BOEI | Sep 19, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Sep 19, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Sep 19, 2024 | 2.60 | +0.39 |
Brederode S.A. | BREB | Sep 19, 2024 | 117.60 | +0.86 |
Campine nv | CAMB | Sep 19, 2024 | 79.00 | -1.25 |
Candela Invest | CAND | Sep 19, 2024 | 3.20 | 0.00 |
Care Property Invest NV/SA | CPINV | Sep 19, 2024 | 14.92 | +0.13 |
Celyad Oncology SA | CYAD | Sep 19, 2024 | 0.25 | -3.10 |
Cenergy Holdings | CENER | Sep 19, 2024 | 10.18 | +3.88 |
Chevron | CHTEX | Sep 19, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Sep 19, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Sep 19, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Sep 19, 2024 | 66.15 | +0.23 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Sep 19, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Sep 19, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Sep 19, 2024 | 43.94 | -0.41 |
Compagnie du Bois Sauvage S.A. | COMB | Sep 19, 2024 | 259.00 | -0.38 |
Compagnie d`Entreprises CFE SA | CFEB | Sep 19, 2024 | 6.75 | +1.20 |
Connect Group | CONN | Sep 19, 2024 | 1.53 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.